Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs121913377

Current Build 155

Released April 9, 2021

Organism
Homo sapiens
Position
chr7:140753335-140753336 (GRCh38.p13) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
CA>AT / CA>TT
Variation Type
MNV Multiple Nucleotide Variation
Frequency
None
Clinical Significance
Reported in ClinVar
Gene : Consequence
BRAF : Missense Variant
Publications
19 citations
Genomic View
See rs on genome
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p13 chr 7 NC_000007.14:g.140753335_140753336delinsAT
GRCh38.p13 chr 7 NC_000007.14:g.140753335_140753336delinsTT
GRCh37.p13 chr 7 NC_000007.13:g.140453135_140453136delinsAT
GRCh37.p13 chr 7 NC_000007.13:g.140453135_140453136delinsTT
BRAF RefSeqGene (LRG_299) NG_007873.3:g.176429_176430delinsAT
BRAF RefSeqGene (LRG_299) NG_007873.3:g.176429_176430delinsAA
Gene: BRAF, B-Raf proto-oncogene, serine/threonine kinase (minus strand)
Molecule type Change Amino acid[Codon] SO Term
BRAF transcript variant 1 NM_004333.6:c.1799_1800de…

NM_004333.6:c.1799_1800delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 1 NP_004324.2:p.Val600Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 1 NM_004333.6:c.1799_1800de…

NM_004333.6:c.1799_1800delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 1 NP_004324.2:p.Val600Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 2 NM_001354609.2:c.1799_180…

NM_001354609.2:c.1799_1800delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 2 NP_001341538.1:p.Val600Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 2 NM_001354609.2:c.1799_180…

NM_001354609.2:c.1799_1800delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 2 NP_001341538.1:p.Val600Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 4 NM_001374244.1:c.1919_192…

NM_001374244.1:c.1919_1920delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 3 NP_001361173.1:p.Val640Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 4 NM_001374244.1:c.1919_192…

NM_001374244.1:c.1919_1920delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 3 NP_001361173.1:p.Val640Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 5 NM_001374258.1:c.1919_192…

NM_001374258.1:c.1919_1920delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 4 NP_001361187.1:p.Val640Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 5 NM_001374258.1:c.1919_192…

NM_001374258.1:c.1919_1920delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 4 NP_001361187.1:p.Val640Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 11 NM_001378472.1:c.1643_164…

NM_001378472.1:c.1643_1644delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 10 NP_001365401.1:p.Val548Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 11 NM_001378472.1:c.1643_164…

NM_001378472.1:c.1643_1644delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 10 NP_001365401.1:p.Val548Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 6 NM_001378467.1:c.1808_180…

NM_001378467.1:c.1808_1809delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 5 NP_001365396.1:p.Val603Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 6 NM_001378467.1:c.1808_180…

NM_001378467.1:c.1808_1809delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 5 NP_001365396.1:p.Val603Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 8 NM_001378469.1:c.1733_173…

NM_001378469.1:c.1733_1734delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 7 NP_001365398.1:p.Val578Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 8 NM_001378469.1:c.1733_173…

NM_001378469.1:c.1733_1734delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 7 NP_001365398.1:p.Val578Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 7 NM_001378468.1:c.1799_180…

NM_001378468.1:c.1799_1800delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 6 NP_001365397.1:p.Val600Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 7 NM_001378468.1:c.1799_180…

NM_001378468.1:c.1799_1800delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 6 NP_001365397.1:p.Val600Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 9 NM_001378470.1:c.1697_169…

NM_001378470.1:c.1697_1698delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 8 NP_001365399.1:p.Val566Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 9 NM_001378470.1:c.1697_169…

NM_001378470.1:c.1697_1698delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 8 NP_001365399.1:p.Val566Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 14 NM_001378475.1:c.1535_153…

NM_001378475.1:c.1535_1536delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 13 NP_001365404.1:p.Val512Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 14 NM_001378475.1:c.1535_153…

NM_001378475.1:c.1535_1536delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 13 NP_001365404.1:p.Val512Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 10 NM_001378471.1:c.1688_168…

NM_001378471.1:c.1688_1689delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 9 NP_001365400.1:p.Val563Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 10 NM_001378471.1:c.1688_168…

NM_001378471.1:c.1688_1689delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 9 NP_001365400.1:p.Val563Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 12 NM_001378473.1:c.1643_164…

NM_001378473.1:c.1643_1644delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 11 NP_001365402.1:p.Val548Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 12 NM_001378473.1:c.1643_164…

NM_001378473.1:c.1643_1644delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 11 NP_001365402.1:p.Val548Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant 13 NM_001378474.1:c.1799_180…

NM_001378474.1:c.1799_1800delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 12 NP_001365403.1:p.Val600Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant 13 NM_001378474.1:c.1799_180…

NM_001378474.1:c.1799_1800delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform 12 NP_001365403.1:p.Val600Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant X2 XM_017012559.1:c.1919_192…

XM_017012559.1:c.1919_1920delinsAT

V [GTG] > D [GAT] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform X2 XP_016868048.1:p.Val640Asp V (Val) > D (Asp) Missense Variant
BRAF transcript variant X2 XM_017012559.1:c.1919_192…

XM_017012559.1:c.1919_1920delinsAA

V [GTG] > E [GAA] Coding Sequence Variant
serine/threonine-protein kinase B-raf isoform X2 XP_016868048.1:p.Val640Glu V (Val) > E (Glu) Missense Variant
BRAF transcript variant X3 XR_001744857.1:n.1927_192…

XR_001744857.1:n.1927_1928delinsAT

N/A Non Coding Transcript Variant
BRAF transcript variant X3 XR_001744857.1:n.1927_192…

XR_001744857.1:n.1927_1928delinsAA

N/A Non Coding Transcript Variant
BRAF transcript variant X4 XR_001744858.1:n. N/A Intron Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: AT (allele ID: 362818 )
ClinVar Accession Disease Names Clinical Significance
RCV000423512.1 Melanoma Pathogenic
Allele: TT (allele ID: 362948 )
ClinVar Accession Disease Names Clinical Significance
RCV000424781.1 Colonic neoplasm Likely-Pathogenic
RCV000442563.1 Melanoma Likely-Pathogenic
Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

None
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement CA= AT TT
GRCh38.p13 chr 7 NC_000007.14:g.140753335_140753336= NC_000007.14:g.140753335_140753336delinsAT NC_000007.14:g.140753335_140753336delinsTT
GRCh37.p13 chr 7 NC_000007.13:g.140453135_140453136= NC_000007.13:g.140453135_140453136delinsAT NC_000007.13:g.140453135_140453136delinsTT
BRAF RefSeqGene (LRG_299) NG_007873.3:g.176429_176430= NG_007873.3:g.176429_176430delinsAT NG_007873.3:g.176429_176430delinsAA
BRAF transcript variant 1 NM_004333.6:c.1799_1800= NM_004333.6:c.1799_1800delinsAT NM_004333.6:c.1799_1800delinsAA
BRAF transcript variant 1 NM_004333.5:c.1799_1800= NM_004333.5:c.1799_1800delinsAT NM_004333.5:c.1799_1800delinsAA
BRAF transcript NM_004333.4:c.1799_1800= NM_004333.4:c.1799_1800delinsAT NM_004333.4:c.1799_1800delinsAA
BRAF transcript variant 2 NM_001354609.2:c.1799_1800= NM_001354609.2:c.1799_1800delinsAT NM_001354609.2:c.1799_1800delinsAA
BRAF transcript variant 2 NM_001354609.1:c.1799_1800= NM_001354609.1:c.1799_1800delinsAT NM_001354609.1:c.1799_1800delinsAA
BRAF transcript variant 5 NM_001374258.1:c.1919_1920= NM_001374258.1:c.1919_1920delinsAT NM_001374258.1:c.1919_1920delinsAA
BRAF transcript variant 6 NM_001378467.1:c.1808_1809= NM_001378467.1:c.1808_1809delinsAT NM_001378467.1:c.1808_1809delinsAA
BRAF transcript variant 9 NM_001378470.1:c.1697_1698= NM_001378470.1:c.1697_1698delinsAT NM_001378470.1:c.1697_1698delinsAA
BRAF transcript variant 10 NM_001378471.1:c.1688_1689= NM_001378471.1:c.1688_1689delinsAT NM_001378471.1:c.1688_1689delinsAA
BRAF transcript variant 7 NM_001378468.1:c.1799_1800= NM_001378468.1:c.1799_1800delinsAT NM_001378468.1:c.1799_1800delinsAA
BRAF transcript variant 14 NM_001378475.1:c.1535_1536= NM_001378475.1:c.1535_1536delinsAT NM_001378475.1:c.1535_1536delinsAA
BRAF transcript variant 11 NM_001378472.1:c.1643_1644= NM_001378472.1:c.1643_1644delinsAT NM_001378472.1:c.1643_1644delinsAA
BRAF transcript variant 4 NM_001374244.1:c.1919_1920= NM_001374244.1:c.1919_1920delinsAT NM_001374244.1:c.1919_1920delinsAA
BRAF transcript variant 8 NM_001378469.1:c.1733_1734= NM_001378469.1:c.1733_1734delinsAT NM_001378469.1:c.1733_1734delinsAA
BRAF transcript variant 12 NM_001378473.1:c.1643_1644= NM_001378473.1:c.1643_1644delinsAT NM_001378473.1:c.1643_1644delinsAA
BRAF transcript variant 3 NR_148928.2:n.2898_2899= NR_148928.2:n.2898_2899delinsAT NR_148928.2:n.2898_2899delinsAA
BRAF transcript variant X2 XM_017012559.1:c.1919_1920= XM_017012559.1:c.1919_1920delinsAT XM_017012559.1:c.1919_1920delinsAA
BRAF transcript variant 3 NR_148928.1:n.2897_2898= NR_148928.1:n.2897_2898delinsAT NR_148928.1:n.2897_2898delinsAA
BRAF transcript variant 13 NM_001378474.1:c.1799_1800= NM_001378474.1:c.1799_1800delinsAT NM_001378474.1:c.1799_1800delinsAA
BRAF transcript variant X3 XR_001744857.1:n.1927_1928= XR_001744857.1:n.1927_1928delinsAT XR_001744857.1:n.1927_1928delinsAA
serine/threonine-protein kinase B-raf isoform 1 NP_004324.2:p.Val600= NP_004324.2:p.Val600Asp NP_004324.2:p.Val600Glu
serine/threonine-protein kinase B-raf isoform 2 NP_001341538.1:p.Val600= NP_001341538.1:p.Val600Asp NP_001341538.1:p.Val600Glu
serine/threonine-protein kinase B-raf isoform 4 NP_001361187.1:p.Val640= NP_001361187.1:p.Val640Asp NP_001361187.1:p.Val640Glu
serine/threonine-protein kinase B-raf isoform 5 NP_001365396.1:p.Val603= NP_001365396.1:p.Val603Asp NP_001365396.1:p.Val603Glu
serine/threonine-protein kinase B-raf isoform 8 NP_001365399.1:p.Val566= NP_001365399.1:p.Val566Asp NP_001365399.1:p.Val566Glu
serine/threonine-protein kinase B-raf isoform 9 NP_001365400.1:p.Val563= NP_001365400.1:p.Val563Asp NP_001365400.1:p.Val563Glu
serine/threonine-protein kinase B-raf isoform 6 NP_001365397.1:p.Val600= NP_001365397.1:p.Val600Asp NP_001365397.1:p.Val600Glu
serine/threonine-protein kinase B-raf isoform 13 NP_001365404.1:p.Val512= NP_001365404.1:p.Val512Asp NP_001365404.1:p.Val512Glu
serine/threonine-protein kinase B-raf isoform 10 NP_001365401.1:p.Val548= NP_001365401.1:p.Val548Asp NP_001365401.1:p.Val548Glu
serine/threonine-protein kinase B-raf isoform 3 NP_001361173.1:p.Val640= NP_001361173.1:p.Val640Asp NP_001361173.1:p.Val640Glu
serine/threonine-protein kinase B-raf isoform 7 NP_001365398.1:p.Val578= NP_001365398.1:p.Val578Asp NP_001365398.1:p.Val578Glu
serine/threonine-protein kinase B-raf isoform 11 NP_001365402.1:p.Val548= NP_001365402.1:p.Val548Asp NP_001365402.1:p.Val548Glu
serine/threonine-protein kinase B-raf isoform X2 XP_016868048.1:p.Val640= XP_016868048.1:p.Val640Asp XP_016868048.1:p.Val640Glu
serine/threonine-protein kinase B-raf isoform 12 NP_001365403.1:p.Val600= NP_001365403.1:p.Val600Asp NP_001365403.1:p.Val600Glu
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

3 SubSNP, 3 ClinVar submissions
No Submitter Submission ID Date (Build)
1 DF-BWCC ss275515232 Nov 22, 2010 (133)
2 CLINVAR ss2137498009 Apr 13, 2017 (150)
3 CLINVAR ss2137504408 Apr 18, 2017 (150)
4 ClinVar RCV000423512.1 Oct 12, 2018 (152)
5 ClinVar RCV000424781.1 Oct 12, 2018 (152)
6 ClinVar RCV000442563.1 Oct 12, 2018 (152)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
RCV000423512.1, ss275515232 NC_000007.14:140753334:CA:AT NC_000007.14:140753334:CA:AT (self)
RCV000424781.1, RCV000442563.1, ss2137498009, ss2137504408 NC_000007.14:140753334:CA:TT NC_000007.14:140753334:CA:TT (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

19 citations for rs121913377
PMID Title Author Year Journal
12068308 Mutations of the BRAF gene in human cancer. Davies H et al. 2002 Nature
14679157 Determinants of BRAF mutations in primary melanomas. Maldonado JL et al. 2003 Journal of the National Cancer Institute
20551065 RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Yang H et al. 2010 Cancer research
20630094 Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. Rubinstein JC et al. 2010 Journal of translational medicine
20818844 Inhibition of mutated, activated BRAF in metastatic melanoma. Flaherty KT et al. 2010 The New England journal of medicine
21639808 Improved survival with vemurafenib in melanoma with BRAF V600E mutation. Chapman PB et al. 2011 The New England journal of medicine
22048237 Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. Kirkwood JM et al. 2012 Clinical cancer research
22281684 Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Prahallad A et al. 2012 Nature
22356324 Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. Sosman JA et al. 2012 The New England journal of medicine
22608338 Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. Falchook GS et al. 2012 Lancet (London, England)
22663011 Improved survival with MEK inhibition in BRAF-mutated melanoma. Flaherty KT et al. 2012 The New England journal of medicine
22735384 Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Hauschild A et al. 2012 Lancet (London, England)
22805292 Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Falchook GS et al. 2012 The Lancet. Oncology
22972589 Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. Patel SP et al. 2013 Cancer
23020132 Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. Flaherty KT et al. 2012 The New England journal of medicine
23031422 Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma. Ponti G et al. 2012 Journal of hematology & oncology
23317446 Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations. Gentilcore G et al. 2013 BMC cancer
23918947 Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma. Ascierto PA et al. 2013 Journal of clinical oncology
25157968 Prospective enterprise-level molecular genotyping of a cohort of cancer patients. MacConaill LE et al. 2014 The Journal of molecular diagnostics
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post596+ae089ad